Notably, we were not only able to confirm CHEK1 aberration (with over-expression) in basal-like tumors (which are enriched for TNBC), but also reveal this aberration in the luminal B subtype, suggesting a possible vulnerability of this more aggressive type of breast cancer. Here, CHEK1 is linked to breast cancer.